on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Life Sciences Investor Forum
On March 11, 2026, Jaguar Health, Inc. (NASDAQ:JAGX) announced that its founder, president, and CEO, Lisa Conte, will present virtually at the Life Sciences Investor Forum. The event will take place on March 12, 2026, at 2:00 PM Eastern and is hosted by VirtualInvestorConferences.com.
The company focuses on developing proprietary prescription drugs from plants for complex gastrointestinal disorders. Its subsidiaries, Napo Pharmaceuticals and Napo Therapeutics, are working on crofelemer powder for the treatment of rare gastrointestinal conditions like microvillus inclusion disease and short bowel syndrome.
A replay of the webcast will be accessible after the conference.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news